BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Johannes Brühl, Moritz Schirren, Christel Wei, Christoph Antoni, Ulrich Böcker. Prospective noninvasive analysis of hepatic fibrosis in patients with Crohn’s diseaseEuropean Journal of Gastroenterology & Hepatology 2011; 23(10): 923 doi: 10.1097/MEG.0b013e3283499252
2
David M. Chascsa, Keith D. Lindor. Cancer risk, screening and surveillance in primary sclerosing cholangitisMinerva Gastroenterologica e Dietologica 2019; 65(3) doi: 10.23736/S1121-421X.19.02586-8
3
Christian Rupp, Konrad Alexander Bode, Fadi Chahoud, Andreas Wannhoff, Kilian Friedrich, Karl-Heinz Weiss, Peter Sauer, Wolfgang Stremmel, Daniel Nils Gotthardt. Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasisBMC Infectious Diseases 2014; 14(1) doi: 10.1186/s12879-014-0562-8
4
Johannes Stallhofer, Gerald Ulrich Denk, Jürgen Glas, Rüdiger Paul Laubender, Burkhard Göke, Christian Rust, Stephan Brand, Thomas Pusl. Analysis of <i>IL2/IL21</i> Gene Variants in Cholestatic Liver Diseases Reveals an Association with Primary Sclerosing CholangitisDigestion 2011; 84(1): 29 doi: 10.1159/000321619
5
Kilian Friedrich, Mark Smit, Maik Brune, Thomas Giese, Christian Rupp, Andreas Wannhoff, Petra Kloeters, Yvonne Leopold, Gerald Ulrich Denk, Karl Heinz Weiss, Wolfgang Stremmel, Peter Sauer, Simon Hohenester, Peter Schirmacher, Peter Schemmer, Daniel Nils Gotthardt. CD14 is associated with biliary stricture formationHepatology 2016; 64(3): 843 doi: 10.1002/hep.28543
6
Harald Hofer, Emina Halilbasic, Katharina Staufer, Michael Trauner. Liver Immunology2014; : 301 doi: 10.1007/978-3-319-02096-9_20
7
Verena Keitel, Maria Reich, Dieter Häussinger. TGR5: Pathogenetic Role and/or Therapeutic Target in Fibrosing Cholangitis?Clinical Reviews in Allergy & Immunology 2015; 48(2-3): 218 doi: 10.1007/s12016-014-8443-x
8
Jörg Jahnel, Peter Fickert, Cord Langner, Christoph Högenauer, Dagmar Silbert, Judith Gumhold, Andrea Fuchsbichler, Michael Trauner. Impact of experimental colitis on hepatobiliary transporter expression and bile duct injury in miceLiver International 2009; 29(9): 1316 doi: 10.1111/j.1478-3231.2009.02044.x
9
Brian D. Juran, Elizabeth J. Atkinson, Erik M. Schlicht, Joseph J. Larson, David Ellinghaus, Andre Franke, Konstantinos N. Lazaridis. Genetic polymorphisms of matrix metalloproteinase 3 in primary sclerosing cholangitisLiver International 2011; 31(6): 785 doi: 10.1111/j.1478-3231.2010.02420.x
10
Klaudia Farkas, Ferenc Nagy, László Kovács, Éva Csajbók, Gabriella Kovács, Tibor Wittmann, Tamás Molnár. Ulcerative colitis and primary sclerosing cholangitis as part of autoimmune polyglandular syndrome type IIIInflammatory Bowel Diseases 2010; 16(1): 10 doi: 10.1002/ibd.20913
11
Christopher L. Bowlus. Cutting Edge Issues in Primary Sclerosing CholangitisClinical Reviews in Allergy & Immunology 2011; 41(2): 139 doi: 10.1007/s12016-010-8221-3
12
HANS-UDO KASPER, DINA LIGUM, JELENA CUCUS, DIRK L. STIPPEL, HANS P. DIENES, UTA DREBBER. Liver distribution of γδ-T-cells in patients with chronic hepatitis of different etiologyAPMIS 2009; 117(11): 779 doi: 10.1111/j.1600-0463.2009.02540.x
13
Lena Berglin, Annika Bergquist, Helene Johansson, Hans Glaumann, Carl Jorns, Sebastian Lunemann, Heiner Wedemeyer, Ewa C. Ellis, Niklas K. Björkström, Patricia Aspichueta. In Situ Characterization of Intrahepatic Non-Parenchymal Cells in PSC Reveals Phenotypic Patterns Associated with Disease SeverityPLoS ONE 2014; 9(8): e105375 doi: 10.1371/journal.pone.0105375
14
Riccardo Manfredi, Ilaria Baglio, Matteo De Iorio, Lucia Camera, Roberto Pozzi Mucelli. Magnetic Resonance Cholangiopancreatography (MRCP)2013; : 77 doi: 10.1007/978-88-470-2844-9_4
15
Kidist K. Yimam, Christopher L. Bowlus. Diagnosis and classification of primary sclerosing cholangitisAutoimmunity Reviews 2014; 13(4-5): 445 doi: 10.1016/j.autrev.2014.01.040
16
Driffa Moussata, Gilles Boschetti, Carmen Stefanescu, Stephane Nancey, Yoram Bouhnik, Bernard Flourie. Isolated ileitis associated with primary sclerosing cholangitis in three patients with Crohn’s diseaseScandinavian Journal of Gastroenterology 2016; 51(6): 727 doi: 10.3109/00365521.2015.1126634
17
Marcel Janse, Laetitia E. Lamberts, Lude Franke, Soumya Raychaudhuri, Eva Ellinghaus, Kirsten Muri Boberg, Espen Melum, Trine Folseraas, Erik Schrumpf, Annika Bergquist, Einar Björnsson, Jingyuan Fu, Harm Jan Westra, Harry J.M. Groen, Rudolf S.N. Fehrmann, Joanna Smolonska, Leonard H. van den Berg, Roel A. Ophoff, Robert J. Porte, Tobias J. Weismüller, Jochen Wedemeyer, Christoph Schramm, Martina Sterneck, Rainer Günther, Felix Braun, Severine Vermeire, Liesbet Henckaerts, Cisca Wijmenga, Cyriel Y. Ponsioen, Stefan Schreiber, Tom H. Karlsen, Andre Franke, Rinse K. Weersma. Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9Hepatology 2011; 53(6): 1977 doi: 10.1002/hep.24307
18
Xinyang Li, Jun Shen, Zhihua Ran. Crosstalk between the gut and the liver via susceptibility loci: Novel advances in inflammatory bowel disease and autoimmune liver diseaseClinical Immunology 2017; 175: 115 doi: 10.1016/j.clim.2016.10.006
19
Evaggelia Liaskou, Gideon M. Hirschfield, M. Eric Gershwin. Mechanisms of tissue injury in autoimmune liver diseasesSeminars in Immunopathology 2014; 36(5): 553 doi: 10.1007/s00281-014-0439-3
20
Marion J. Pollheimer, Emina Halilbasic, Peter Fickert, Michael Trauner. Pathogenesis of primary sclerosing cholangitisBest Practice & Research Clinical Gastroenterology 2011; 25(6): 727 doi: 10.1016/j.bpg.2011.10.009
21
Roberta E. Rossi, Dario Conte, Sara Massironi. Primary sclerosing cholangitis associated with inflammatory bowel diseaseEuropean Journal of Gastroenterology & Hepatology 2016; 28(2): 123 doi: 10.1097/MEG.0000000000000532
22
Andreas E Kremer, Christian Rust, Peter Eichhorn, Ulrich Beuers, Stefan Holdenrieder. Immune-mediated liver diseases: programmed cell death ligands and circulating apoptotic markersExpert Review of Molecular Diagnostics 2009; 9(2): 139 doi: 10.1586/14737159.9.2.139
23
Beate E. Preuß, Christoph P. Berg, Christoph Werner, Sandra Plankenhorn, Nisar P. Malek, Reinhild Klein. Sulphite oxidase (SO) – a mitochondrial autoantigen as target for humoral and cellular immune reactions in primary sclerosing cholangitisBMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0787-x
24
Crystal Knight, Karen F Murray. Hepatobiliary associations with inflammatory bowel diseaseExpert Review of Gastroenterology & Hepatology 2009; 3(6): 681 doi: 10.1586/egh.09.53
25
Dimitrios P. Bogdanos, Bin Gao, M. Eric Gershwin. Comprehensive Physiology2013;  doi: 10.1002/cphy.c120011
26
J. -R. Delpero, M. Giovannini. Post’U FMC-HGE2009; : 104 doi: 10.1007/978-2-287-99247-6_13
27
Yu Gao, Jingwei Shao, Zhou Jiang, Jianzhong Chen, Songen Gu, Suhong Yu, Ke Zheng, Lee Jia. Drug enterohepatic circulation and disposition: constituents of systems pharmacokineticsDrug Discovery Today 2014; 19(3): 326 doi: 10.1016/j.drudis.2013.11.020
28
Man Li, Hao Zheng, Qing-bao Tian, Mei-na Rui, Dian-wu Liu. HLA-DR Polymorphism and Primary Biliary Cirrhosis: Evidence From a Meta-analysisArchives of Medical Research 2014; 45(3): 270 doi: 10.1016/j.arcmed.2014.03.002
29
Albert Parés. Colangitis esclerosante primaria: diagnóstico, pronóstico y tratamientoGastroenterología y Hepatología 2011; 34(1): 41 doi: 10.1016/j.gastrohep.2010.02.006
30
Alberto Quaglia. Practical Hepatic Pathology: A Diagnostic Approach2011; : 383 doi: 10.1016/B978-0-443-06803-4.00027-7
31
Francesca Saffioti, Kurinchi Selvan Gurusamy, Neil Hawkins, Clare D Toon, Emmanuel Tsochatzis, Brian R Davidson, Douglas Thorburn. Pharmacological interventions for primary sclerosing cholangitisCochrane Database of Systematic Reviews 2017;  doi: 10.1002/14651858.CD011343.pub2
32
Michael H. Trauner. Molecular Pathology of Liver DiseasesMolecular Pathology Library 2011; 5: 475 doi: 10.1007/978-1-4419-7107-4_32
33
E. L. Culver, R. W. Chapman. Systematic review: management options for primary sclerosing cholangitis and its variant forms - IgG4-associated cholangitis and overlap with autoimmune hepatitisAlimentary Pharmacology & Therapeutics 2011; 33(12): 1273 doi: 10.1111/j.1365-2036.2011.04658.x
34
Roger W. Chapman. Primary sclerosing cholangitisMedicine 2011; 39(10): 588 doi: 10.1016/j.mpmed.2011.07.003
35
George F. Mells, Arthur Kaser, Tom H. Karlsen. Novel insights into autoimmune liver diseases provided by genome-wide association studiesJournal of Autoimmunity 2013; 46: 41 doi: 10.1016/j.jaut.2013.07.004
36
Kurinchi Selvan Gurusamy, Francesca Saffioti, Clare D Toon, Emmanuel Tsochatzis, Brian R Davidson, Douglas Thorburn, Kurinchi Selvan Gurusamy. Cochrane Database of Systematic Reviews2014;  doi: 10.1002/14651858.CD011343
37
Pietro Invernizzi. Primary sclerosing cholangitis is changing clinical spectrum and old biomarkers disclose an innovative role: The case of alkaline phosphataseDigestive and Liver Disease 2011; 43(4): 268 doi: 10.1016/j.dld.2011.02.006
38
Marion J. Pollheimer, Michael Trauner, Peter Fickert. Will we ever model PSC? – “It's hard to be a PSC model!”Clinics and Research in Hepatology and Gastroenterology 2011; 35(12): 792 doi: 10.1016/j.clinre.2011.04.014
39
Maria IS Achenza, Francesca Meda, Enrico Brunetta, Carlo Selmi. Serum autoantibodies for the diagnosis and management of autoimmune liver diseasesExpert Review of Gastroenterology & Hepatology 2012; 6(6): 717 doi: 10.1586/egh.12.58
40
Peter Fickert, Marion J. Pollheimer, Ulrich Beuers, Carolin Lackner, Gideon Hirschfield, Chantal Housset, Verena Keitel, Christoph Schramm, Hanns-Ulrich Marschall, Tom H. Karlsen, Espen Melum, Arthur Kaser, Bertus Eksteen, Mario Strazzabosco, Michael Manns, Michael Trauner. Characterization of animal models for primary sclerosing cholangitis (PSC)Journal of Hepatology 2014; 60(6): 1290 doi: 10.1016/j.jhep.2014.02.006
41
Pietro Invernizzi. Geoepidemiology of autoimmune liver diseasesJournal of Autoimmunity 2010; 34(3): J300 doi: 10.1016/j.jaut.2009.12.002
42
Andrea T. Borchers, Shinji Shimoda, Christopher Bowlus, Carl L. Keen, M. Eric Gershwin. Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitisSeminars in Immunopathology 2009; 31(3): 309 doi: 10.1007/s00281-009-0167-2
43
Kerem Sebib Korkmaz, Bert-Jan F. de Rooij, Bart van Hoek, Marcel Janse, Minneke J. Coenraad, Johan J. van der Reijden, Rinse K. Weersma, Robert J. Porte, Philip W. Voorneveld, Andrzej G. Baranski, Hein W. Verspaget. MMP-2 is a disease-modifying gene in primary sclerosing cholangitisLiver International 2014; 34(2): 274 doi: 10.1111/liv.12237
44
Jonathan H. Aron, Christopher L. Bowlus. The immunobiology of primary sclerosing cholangitisSeminars in Immunopathology 2009; 31(3): 383 doi: 10.1007/s00281-009-0154-7
45
Krisztina Hagymási, Zsolt Tulassay. Review of overlap syndromes of autoimmune liver diseases. Difficulties in the diagnosis and treatmentOrvosi Hetilap 2013; 154(24): 923 doi: 10.1556/OH.2013.29640
46
A. M. Arenas-Gamboa, J. J. Bearss, G. B. Hubbard, B. F. Porter, M. A. Owston, E. J. Dick Jr. Sclerosing Cholangitis in Baboons (Papiospp) Resembling Primary Sclerosing Cholangitis of HumansVeterinary Pathology 2012; 49(3): 524 doi: 10.1177/0300985811419532
47
Dimitrios Bogdanos, Patrick S.C. Leung, M. Eric Gershwin. Mucosal Immunology2015; : 1695 doi: 10.1016/B978-0-12-415847-4.00087-2
48
Roger W. Chapman. Primary sclerosing cholangitisMedicine 2015; 43(11): 648 doi: 10.1016/j.mpmed.2015.08.003
49
C. Buffet. Cholangites sclérosantesEMC - Hépatologie 2011; 6(1): 1 doi: 10.1016/S1155-1976(11)50375-4
50
Corma MA Otte, Jan Rothuizen, Robert P Favier, Louis C Penning, Sandra Vreman. A morphological and immunohistochemical study of the effects of prednisolone or ursodeoxycholic acid on liver histology in feline lymphocytic cholangitisJournal of Feline Medicine and Surgery 2014; 16(10): 796 doi: 10.1177/1098612X14520811
51
Heather Francis, Cynthia J. Meininger. A review of mast cells and liver disease: What have we learned?Digestive and Liver Disease 2010; 42(8): 529 doi: 10.1016/j.dld.2010.02.016
52
Sina Fuchs, Monika Bayer, Richard Taubert, Michael P. Manns, Josef M. Pfeilschifter, Urs Christen, Edith Hintermann. Effects of adenovirus‐induced hepatocyte damage on chronic bile duct inflammation in a sclerosing cholangitis mouse modelLiver International 2019; 39(12): 2330 doi: 10.1111/liv.14183
53
Babunilayam Gangadharan, Bernadette M Dutia, Susan M Rhind, Anthony A Nash. Murid herpesvirus-4 induces chronic inflammation of intrahepatic bile ducts in mice deficient in gamma-interferon signallingHepatology Research 2009; 39(2): 187 doi: 10.1111/j.1872-034X.2008.00440.x
54
Emmanouil Sinakos, Keith Lindor. Treatment options for primary sclerosing cholangitisExpert Review of Gastroenterology & Hepatology 2010; 4(4): 473 doi: 10.1586/egh.10.33